The best discrimination between SVD and AD was obtained by combining a panel of different biomarkers reflecting AD neurobiology (Aβ42, p-tau and t-tau), axonal damage (NfL), demyelination (MBP) and matrix remodeling pathway (TIMP-1 and matrix metalloproteinases) [89]. This evidence concerns the gene TIMP1 and Alzheimer disease.